FindTrial
Sign In

Single infusion of donor liver graft derived NK cells to the recipient 3 days after liver trasplantation

2 trials

Sponsors

Ohdan Hideki, Hiroshima University

Conditions

Decompensated liver cirrhosis patients who will receive liver transplantationdecompensated liver cirrhosis patients who will receive liver transplantation

Phase 2

Liver NK cell therapy for preventing infection after liver transplant
Active, not recruitingJPRN-jRCTa060190036
Ohdan HidekiDecompensated liver cirrhosis patients who will receive liver transplantation
Start: 2016-03-08Target: 37Updated: 2026-06-29

Unknown Phase

Adoptive immunotherapy using donor liver graft derived natural killer (NK) cells for preventing severe infection after liver transplantation
RecruitingJPRN-UMIN000019183
Hiroshima Universitydecompensated liver cirrhosis patients who will receive liver transplantation
Start: 2015-11-25Target: 37Updated: 2026-06-29

Related Papers

A phase I/II study of adoptive immunotherapy using donor liver graft-derived natural killer cells to prevent bloodstream infection after liver transplantation: a study protocol
Translational Medicine Communications2022-08-035 citations